Silo Pharma, Inc. (SILO) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US82711P3001
Silo Pharma, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 72,102.00 USD |
| Gross profit | 27,807.00 USD |
| Operating income | -4.28 m USD |
| EBIT | -4.19 m USD |
| Net income | -4.23 m USD |
| Diluted EPS – continuing operations | -0.50 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Silo Pharma, Inc.
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
More stocks
- Strive, Inc. (ASST)
- Polomar Health Services, Inc. (PMHS)
- VisitIQ Corp. (VIIQ)
- Borqs Technologies, Inc. (BRQSF)
- CXApp Inc. (CXAI)
- Xenetic Biosciences, Inc. (XBIO)
- MANGOCEUTICALS, INC. (MGRX)
- zSpace, Inc. (ZSPC)
- Dragonfly Energy Holdings Corp. (DFLI)
- SelectQuote, Inc. (SLQT)
- SOCKET MOBILE, INC. (SCKT)
- Golden Minerals Co (AUMN)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.